pulmonary hypertension; very fatigued; sleeping 15 hr a day; high heart rate of 200bpm; dizzy/lightheaded; difficulty thinking; difficulty breathing; unable to walk to the bathroom on my own; became very weak; air trapping in my lungs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 21-year-old female patient received BNT162b2 (BNT162B2), on 19Aug2021 at 15:35 as dose 1, single (Lot number: FA7485) at the age of 20 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Attention deficit hyperactivity disorder" (unspecified if ongoing). Concomitant medication(s) included: VYVANSE; SYEDA. Past drug history included: Sodium laurel sulfate, reaction(s): "Allergy". The following information was reported: PULMONARY HYPERTENSION (disability, medically significant), outcome "recovered with sequelae"; FATIGUE (disability), outcome "recovered with sequelae", described as "very fatigued"; HYPERSOMNIA (disability), outcome "recovered with sequelae", described as "sleeping 15 hr a day"; HEART RATE INCREASED (disability), outcome "recovered with sequelae", described as "high heart rate of 200bpm"; DIZZINESS (disability), outcome "recovered with sequelae", described as "dizzy/lightheaded"; MENTAL IMPAIRMENT (disability), outcome "recovered with sequelae", described as "difficulty thinking"; DYSPNOEA (disability), outcome "recovered with sequelae", described as "difficulty breathing"; GAIT DISTURBANCE (disability), outcome "recovered with sequelae", described as "unable to walk to the bathroom on my own"; ASTHENIA (disability), outcome "recovered with sequelae", described as "became very weak"; LUNG DISORDER (disability), outcome "recovered with sequelae", described as "air trapping in my lungs". The events "pulmonary hypertension", "very fatigued", "sleeping 15 hr a day", "high heart rate of 200bpm", "dizzy/lightheaded", "difficulty thinking", "difficulty breathing", "unable to walk to the bathroom on my own", "became very weak" and "air trapping in my lungs" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Heart rate: (unspecified date) 200 bpm, notes: high heart rate; investigation: (unspecified date) air trapping in my lungs confirmed, notes: air trapping in my lungs confirmed, and possibly pulmonary hypertension; SARS-CoV-2 test: (26Dec2021) Positive; (30May2022) Negative. Therapeutic measures were taken as a result of pulmonary hypertension, fatigue, hypersomnia, heart rate increased, dizziness, mental impairment, dyspnoea, gait disturbance, asthenia, lung disorder.  Clinical course: Patient reported that she from a student athlete to being very fatigued, sleeping 15 hour a day high heart rate of 200bpm, even when watching Netflix, dizzy, lightheaded, difficulty thinking, and breathing, and unable to walk to the bathroom on her own or care for herself, became very weak developed air trapping in her lungs confirmed, and possibly pulmonary hypertension, in and out of the ER for 6 months and mostly on bed rest during that time. Patient treatment included prednisone, symbicort, albuterol, lorazepam. Patient was not pregnant at the time of vaccination. Facility type vaccine: Pharmacy or drug store. No other vaccine in four weeks. Patient was taking generic allergy (unspecified). Patient had covid Prior vaccination and was covid tested post vaccination. Known allergies included sodium laurel sulfate.